Controversies in antenatal corticosteroids
AL Shanks, JL Grasch, SK Quinney… - Seminars in Fetal and …, 2019 - Elsevier
Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and
morbidity after preterm birth. However, this translational success story is not without …
morbidity after preterm birth. However, this translational success story is not without …
Controversies in antenatal corticosteroids
AL Shanks, JL Grasch, SK Quinney… - Seminars in Fetal and …, 2019 - sfnmjournal.com
Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and
morbidity after preterm birth. However, this translational success story is not without …
morbidity after preterm birth. However, this translational success story is not without …
Controversies in antenatal corticosteroids
AL Shanks, JL Grasch… - Seminars in fetal & …, 2019 - pubmed.ncbi.nlm.nih.gov
Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and
morbidity after preterm birth. However, this translational success story is not without …
morbidity after preterm birth. However, this translational success story is not without …
Controversies in antenatal corticosteroids.
AL Shanks, JL Grasch, SK Quinney… - Seminars in Fetal & …, 2019 - europepmc.org
Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and
morbidity after preterm birth. However, this translational success story is not without …
morbidity after preterm birth. However, this translational success story is not without …